Loss of PUMA (BBC3) does not prevent thrombocytopenia caused by the loss of BCL-XL (BCL2L1)

Grants

Funding Acknowledgements

We thank Drs P. Bouillet, J. M. Adams, L. Hennighausen and A. Villunger for mice; E. Major, S. Ross, T. Carle, T. Gibbs, S. Green, C. Gall, S. O'Connor, J. Mansheim, K. McKenzie and G. Siciliano for outstanding animal husbandry; B. Helbert for genotyping; J. Corbin and J. McManus for automated blood analysis. This work was supported by a Project Grant (575535), Program Grants (1016701, 1016647), Fellowships (AS Australia Fellowship 1020363, BTK 1063008) and an Independent Research Institutes Infrastructure Support Scheme Grant (361646) from the Australian National Health and Medical Research Council; a fellowship from the Sylvia and Charles Viertel Foundation (BTK); the Australian Cancer Research Fund; the Cancer Council of Victoria (SG, ARDD); Leukaemia Foundation Australia (SG); the Lady Tata Memorial Trust (SG); Cure Brain Cancer Australia (AS); the Leukemia and Lymphoma Society (AS, SOCR Grant #7001-03), Melbourne International Research and the Melbourne International Fee Remission Scholarship (University of Melbourne, SG) and Cancer Therapeutics CRC Top up Scholarship (SG, ARDD). The estate of Anthony (Toni) Redstone OAM, University of Melbourne International Research and International Fee Remission Scholarships (SG), Australian Postgraduate Award (ARDD), and the operational infrastructure grants through the Australian Government TRESS and the Victorian State Government OIS.